| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K61166597 |
| PharmacoGx | BRD-K61166597 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | POLR1A | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | VEPH1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | WHSC1L1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | NRXN2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | E4F1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | CNGB3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | MURC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | RRBP1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | CECR2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | SEMA3G | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
